Reviva Pharmaceuticals Holdings, Inc. reports results for the quarter - Earnings Summary

Reviva Pharmaceuticals Holdings

15/11/2024 14:01

* Reviva Pharmaceuticals Holdings, Inc.  RVPH.OQ  reported a
quarterly adjusted loss of 25 cents​​ per share for the quarter
, higher than the same quarter last year, when the company
reported EPS of -44 cents.  The mean expectation of six analysts
for the quarter was for a loss of 25 cents per share. Wall
Street expected results to range from -31 cents to -20 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Reviva Pharmaceuticals Holdings, Inc.'s reported EPS for
the
quarter was a loss of 25 cents​.
    * The company reported a quarterly loss of $8.37 million.
    * Reviva Pharmaceuticals Holdings, Inc. shares had fallen
by 16.0%
this quarter and lost 76.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 12.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Reviva
Pharmaceuticals Holdings, Inc. is $15.00 
This summary was machine generated from LSEG data November 15 at
02:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.25          -0.25          Met
 Jun. 30 2024      -0.29          -0.26          Beat
 Mar. 31 2024      -0.38          -0.25          Beat
 Dec. 31 2023      -0.35          -0.35          Met